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Abstract
Inflammation is part of a complex physiological response to harmful stimuli and pathogenic stress. The five components of
the Nuclear Factor kB (NF-kB) family are prominent mediators of inflammation, acting as key transcriptional regulators of
hundreds of genes. Several signaling pathways activated by diverse stimuli converge on NF-kB activation, resulting in a
regulatory system characterized by high complexity. It is increasingly recognized that the number of components that
impinges upon phenotypic outcomes of signal transduction pathways may be higher than those taken into consideration
from canonical pathway representations. Scope of the present analysis is to provide a wider, systemic picture of the NF-kB
signaling system. Data from different sources such as literature, functional enrichment web resources, protein-protein
interaction and pathway databases have been gathered, curated, integrated and analyzed in order to reconstruct a single,
comprehensive picture of the proteins that interact with, and participate to the NF-kB activation system. Such a
reconstruction shows that the NF-kB interactome is substantially different in quantity and quality of components with
respect to canonical representations. The analysis highlights that several neglected but topologically central proteins may
play a role in the activation of NF-kB mediated responses. Moreover the interactome structure fits with the characteristics of
a bow tie architecture. This interactome is intended as an open network resource available for further development,
refinement and analysis.
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Introduction
Inflammation, a complex, pervasive process
Inflammation is a complex, systemic, multi-scale physiological
process necessary to cope with damaging agents and fundamental
for survival, involving a variety of cells, organs and organ systems.
The complexity of the inflammatory process has escaped
reductionist and linear approaches, since it is characterized,
among other features, by non-proportional kinetics as well as
numerous and nested feedback loops [1]. Apart from its protective,
physiological role, inflammation is an important concomitant
cause of many major age-associated pathologies, such as cancer,
neurodegeneration, Type II Diabetes and metabolic syndromes
[2]. To this regard, it has been observed that a systemic, chronic,
low-grade inflammatory status characterizes the aging process,
and that markers of inflammation increase with age [3–7]. We
proposed to indicate this phenomenon as ‘‘inflammaging’’ [8–10].
In this perspective, we hypothesised that the phenomenon of
inflammaging, likely resulting from the chronic exposure to
environmental stressors such as chronic viral infections [6,11],
can be an important cause of these age-associated diseases, and
therefore the genetic control of inflammation appears to be a
crucial determinant of longevity, today a pressing topic given the
aging of population all over the world.
A pivotal player of the inflammatory response is the NF-kB
(nuclear factor kappa-light-chain-enhancer of activated B cells)
transcription factor. Able to be activated by a great number of
stimuli and to participate in the regulation of hundreds of genes
[12,13], NF-kB has a wide spectrum of actions, such as to induce
survival and proliferation, and in particular it is considered the
master regulator of inflammation [14]. Thus, it is of great interest
to deepen the basic knowledge regarding the topology and the
dynamics of the signaling pathways and regulatory network
underpinning the activation of such a pleiotropic transcription
factor. While the literature dedicated to specific aspects of NF-kB
functions or regulation is huge, a wider representation of its
complex regulating system is still missing.
The NF-kB system
NF-kB is a protein complex that both induces and represses
gene expression by binding to discrete DNA sequences, known as
kB elements, in gene promoters and enhancers [15,16]. In
mammalian cells, there are five NF-kB family members, RelA
(p65), RelB, c-Rel, p50/p105 (NF-kB1) and p52/p100 (NF-kB2),
and different NF-kB complexes are formed from their homo- and
hetero-dimers. All proteins of the NF-kB family share a Rel
homology domain. Moreover, RelA, RelB, and c-Rel have a
transactivation domain in their C-terminus required for gene
activation. NF-kB 1 and NF-kB 2 proteins are synthesized as large
precursors, p105 and p100, which undergo processing to generate
the mature NF-kB subunits, p50 and p52, respectively. The
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proteasome pathway and involves selective degradation of their C-
terminal region containing ankyrin repeats. Whereas the gener-
ation of p52 from p100 is a tightly-regulated process, p50 is
produced from constitutive processing of p105 [16]. Additionally,
the ubiquitin proteasome system controls NF-kB activation also by
the degradation of inhibitory proteins, including IkBs members,
but there is evidence for different downstream level of NF-kB
regulation that employs several non proteolytic mechanisms,
including promoter-specific exchange of dimers and modification
of the transactivating p65 subunit by post translational modifica-
tion, such as phosphorylation, acetylation and ubiquitination [17].
In vertebrates, NF-kB is activated by over 150 different stimuli,
such as stress, cytokines, free radicals, ultraviolet irradiation,
oxidized LDL and bacterial or viral antigens [12]. In turn, there is
evidence that active NF-kB participates in the control of
transcription of more than 400 genes [13]. These genes include
cytokines, chemokines and their modulators, immunoreceptors,
proteins involved in antigen presentation, cell adhesion molecules,
acute phase proteins, stress response proteins, cell-surface
receptors, regulators of apoptosis, growth factors, ligands and
their modulators, early response proteins, transcription factors and
regulators, and enzymes, controlling several phenomena such as
inflammation as well as innate and adaptive immune response
[16]. Considering the central role of NF-kB in maintaining cellular
homeostasis, it is not surprising that dysregulation of its finely
tuned modulation has often been linked to the development of
several disorders, most of which with an inflammatory component
such as cancer, autoimmune diseases, and chronic inflammatory
disorders [18,19].
Twenty-five years of research efforts [20] have not been enough
for a sufficient comprehension of NF-kB dynamics [21], and
gaining insights into NF-kB and related processes is still a top
priority for the understanding of the onset of associated diseases
[20].
Moving from NF-kB pathway to NF-kB interactome
network
It is increasingly recognized that the number of components
that impinge upon phenotypic outcomes of signal transduction
pathways may be higher than that taken into consideration from
canonical representations [22–24]. Indeed, recent screens suggest
the participation of hundreds of components, instead of the dozens
classically involved in canonical signaling pathway representations
[22], proposing a switch from linear or branched signal cascades to
networks with complex interdependencies and feedbacks. More-
over, the interpretation of new findings [23] suggests that cell
functionality may be based on a single ‘‘mega-network with limited
isolation’’ [22] between pathways’ elements, modules (i.e. a set of
proteins capable of independent functionality) and networks. The
difficulty in drawing contours and boundaries of signaling
pathways becomes more evident when the study of the system is
approached with formal engineering failure analysis [25]. Systems
biology approaches may provide crucial clues about the
architecture and the logic of the regulation of the NF-kB system
and related gene expression [20]. Moreover, comprehensive maps
of complex signaling pathways are proving to be important tools to
facilitate systems-level study [26,27].
Signaling crosstalk and combinatorial control of NF-kB
pathway are very complex [28–31]. In-depth studies often report
fragmented knowledge, since they forcedly focus only on a limited
part of the puzzle. In this scenario limiting analyses to canonical
NF-kB pathway elements may reveal inadequate in unveiling
crucial mechanisms or players in the regulation of this system. The
aim of this work is to integrate into one single, more
comprehensive and less ‘‘pathway-centric’’ [22] picture all the
proteins that, on the basis of present knowledge, interact directly
or indirectly with the fundamental NF-kB-activation proteins to
compose the ‘‘NF-kB pathway interactome’’. We propose that
such approach may give further insights on the contribution of
components that would have been neglected in a more canonical
perspective. Such a comprehensive approach may provide insights
about how specific stimuli trigger particular subsets of NF-kB-
target genes [21], or about the regulatory hierarchy that rules the
selection of target gene expression [32]. To do this, we mined from
multiple sources and integrated in an unitary view manually
collected data from literature, binary protein-protein interaction
(PPI) data, protein annotation data, and NF-kB downstream genes
data. We compiled three different sets of proteins that show
evidence of involvement in the upstream regulation process of NF-
kB, and one set of downstream genes (and related proteins) which
expression appears to be regulated by NF-kB. Starting from these
sets, we reconstructed three NF-kB protein interaction networks
(PINs), or interactomes, by using PPI data from multiple
databases, and then checked for the existence of physical
interactions between these upstream protein sets and the
downstream set. The resulting interactomes also underwent
functional enrichment and network analysis to highlight their
composition and structure.
Materials and Methods
Part of data retrieval, interactome reconstruction and analysis
have been performed with the use of the Cytoscape network
analysis platform [33–35] and following a general workflow also
described in [36]. For PPI data and interactome reconstruction,
we used the Agile Protein Interaction Database (APID) [37], a
comprehensive resource for protein interaction data, automatically
accessed by Cytoscape through the dedicated plugin APID2NET
[38]. APID integrates in a single web-based tool all known
experimentally validated protein-protein interactions from BIND,
BioGRID, DIP, HPRD, IntAct and MINT databases. Annotation
and pathway data have been collected mainly from the Universal
Protein Resource (UniProt) and the Kyoto Encyclopedia of Genes
and Genomes (KEGG), accessed through the suites FaTiGO [39]
and Babelomics [40,41]. Additional information on disease
pathways have been accessed through DisGeNET [42], and the
Pharmacogenomics Knowledge Base PharmGKB [43]. All
databases and platforms used here are free and open access.
The complete protein lists and relative analysis results are
provided in tables S1, S2, S3 and dataset S1. Note that we refer
to a ‘‘set’’ as to a list of proteins, and to ‘‘interactome’’ as to a
network whose elements are (all or a part of) the proteins of the
respective set, enriched with the available protein interaction data.
Interactome acronyms are indicated with a capital ‘‘I’’ after the
acronym of the respective set.
The network analysis have been performed using the Cytoscape
platform and the plugins Networkanalyzer [44] and MCODE
[45]. Besides classical parameters (node degree and betweenness
centrality, among others), we also calculated the network density
(the average number of neighbors for each node), and the network
centralization. The degree of a node is the number of edges linked
to it. In this case, it is the number of physical interactions that a
specific protein shows with other proteins. The betweenness
centrality of a node attests the grade of control that this node
exerts over the interactions of other nodes in the network, and its
biological relevance has been demonstrated [46,47]. The average
number of neighbours (connectivity) of a node in the network may
A Comprehensive Map of the NF-kB Signaling System
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parameter, i.e. the network density. The density is a value between
0 and 1, and shows how densely the network is populated with
links. In calculating density, self-loops are ignored (self-loops are
evidence based interactions between two copies of the same
protein [44]). Network centrality is a parameter which value
ranges between 0 and 1. Networks whose topologies resemble a
star (i.e. with a relatively well defined central core) have a
centrality close to 1, whereas decentralized networks are
characterized by having a centrality close to 0. The interactomes
are completely available in Cytoscape format (.cys) in the Dataset
S1.
Directly Interacting (DI) NF-kB proteins dataset
The directly-NF-kB-interacting protein set, or hereinafter
Direct Interactome, (DI) (fig. 1a), is composed by all the proteins
that show experimental evidence of physical interaction with at
least one of the five NF-kB members. Given the procedure used
(search for directly NF-kB-interacting proteins), in the case of DI,
the protein set coincides with the respective interactome. Data
retrieval has been performed with APID2NET and Cytoscape.
The query returned a total of 377 proteins (including the five NF-
kB members). The DI accounts for 4,119 non-directional
interactions (including self-interactions).
Uniprot (U) NF-kB annotated proteins dataset
To populate the set U, we searched the UniProt Knowledge
Base with the parameters: «annotation:(type: nonpositional ‘‘nf kappa b’’)
and organism: ‘‘Homo sapiens (Human) [9606]’’» and we retrieved a list
of 235 proteins that have been manually screened and checked to
obtain a final, validated list of 229 proteins with evidence of
implications in the NF-kB functioning (see Table S1 for
Figure 1. The three interactomes DI (a), UI (b) and MCI (c) and the resulting UNION interactome (d) as from Cytoscape layout,
available in the Dataset S1 as .cys file. Datasets and interactomes have been reconstructed following procedures described in materials and
methods section. Nodes represent proteins and links are evidence-based physical interactions. Node size and color are proportional to betweenness
centrality values (red: high, green: low; not comparable among different interactomes). Isolated proteins show no evidence of physical interactions
with any other proteins within the same dataset.
doi:10.1371/journal.pone.0032678.g001
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tion data are retrieved in order to reconstruct the relative
interactome. Two hundred and ten proteins (210), out of 229,
are present in the APID database, from which interaction data
have been downloaded, and constitute the Uniprot interactome
(UI, fig. 1b). One hundred and fifty proteins (out of 210) form a
main cluster, accounting for 550 interactions, while other 60 are
isolated from the main cluster.
Manually Curated (MC) proteins dataset
We selected and then manually screened a collection of 37 top
quality, highly cited literature papers regarding NF-kB to identify
proteins that take part with different roles and functions to the
signalling cascade leading to NF-kB activation [14,17,48–82]. The
criteria for protein selection and inclusion in the MC set are based
on its presence and function described in each paper, either as
directly involved in the cascade dynamics (e.g. interacting protein),
or collaterally participating with a function identified and
described in the articles considered. One hundred and forty one
proteins (141) have been identified. Again, PPI data have been
added (through the use of the APID database) to build the
Manually Curated interactome (MCI), that accounts for 853 non-
directional interactions (including self-interactions) (fig. 1c). All
proteins in the DI, U and MC sets are considered to work
upstream NF-kB, i.e. to participate with a variable role to the
modulation and to the signalling cascade leading to NF-
kBactivation.
Downstream Genes (DG) dataset
Data extracted from a manually curated list of NF-kB-
downstream genes (www.nf-kb.org; [13]) and from the Transcrip-
tional Regulatory Elements Database (TRED; [83,84]) constitute a
list of 441 genes that result to be up- or down-regulated in response
to the activation of at least one of the NF-kB family members
(Table S2). Four hundred forty one (441) valid ENSEMBL gene
identifiers mapping to 426 related protein unique identifiers
(Uniprot IDs) have been obtained using online ID converter tools
[85]. The Babelomics suite for functional analysis identified 16
duplicates leading to a valid list of 410 IDs. Three hundred and
eighty four (384) out of 426 protein IDs have been found in the
APID database, used for DG interactome reconstruction.
Results
Composition and analysis of the protein sets and
interactomes
The three sets DI, U and MC (and corresponding interactomes
DI, UI and MCI) show substantial differences with one another in
their dimensions and structure as well as in the protein
composition. We also considered the interactome resulting from
the union of DI, UI and MCI (DI < UI < MCI; hereinafter
UNION, Figure 1d), which accounts for 622 proteins and 6,115
interactions (see table 1 for the main parameters) in order to have
the widest possible picture of the elements participating in the NF-
kB system. The intersection of all three sets (the proteins shared by
all three sets: DI > UI > MCI) accounts for only 16 proteins and
89 interactions (see fig. 2 and Dataset S1). The intersection should
represent the very ‘‘core’’ of the system. Indeed it contains the 5
members of the NF-kB family (p65, RelB, c-Rel, NF-kB1, NF-
kB2), the 4 members of the inhibitor of NF-kB( I kB) family (IkBa,
IkBb,I kBe, BCL-3) and the three core subunits of the IkB kinase
(IKK) complex (NEMO, IKKa, IKKb) as reported by Perkins
[14]. Other components of this core subset are IKBKE,
MAP3K14, TRAF3 and NKRF, which are very well known
elements able to activate or inhibit NF-kB [86–89]. The MCI is
the most dense and less populated by self-loops, while the UNION
shows high average neighbours value but also many self-loops
(Table 1). The most centralised interactome is the DI, while the UI
is the most decentralized (Table 1).
Network analysis showed that, as expected, being these
networks centred on NF-kB, the five NF-kB subunits are among
the most central elements for betweenness centrality values
(Table 2). This condition is common to all 3 interactomes. The
betweenness centrality of a node attests the amount of control
exerted by this node over the capability of interaction of other
nodes in the network. In particular, four out of five NF-kB
components are in the first five positions for betweenness centrality
in the UNION set (table 2; complete list available in Dataset S1),
while REL is ranked 21
st. Among the highest ranking proteins,
TRAF6, at third position, is the element of connection of crucial
membrane receptors. It is a member of the TNF receptor
associated factor (TRAF) protein family, and mediates signal
transduction from members of the TNF receptor superfamily and
of the Toll/IL-1 family [90]. The connection between these two
receptor families is interesting because the Toll-Like Receptors
(TLRs) and TNF receptors (TNFRs) play the role of external
sensors for NF-kB pathway activation. TLRs take a crucial part in
early host defense against invading pathogens, recognizing many
pathogen-associated molecular patterns (PAMPs), including bac-
terial cell-surface lipopolysaccharides, peptidoglycans and lipopro-
teins, viral double-stranded RNA and viral single-stranded RNA,
bacterial and viral CpG, as recently reviewed [91]; TNFR is the
mediator of TNF effects, one of the universal effectors of innate
signaling, involved in host defense and inflammation [92].
Table 2 also shows that three broad activatorsof gene transcription
such as Myc, p53 and STAT3 are found as central elements at
position 13, 20 and 25, respectively. This reflects the fact that NF-kB
is not only important for linking adaptive and innate immunity but it
is also at the verycentre of fundamental cell defensemechanismssuch
as stress response, as well as of other basic cellular functions such as
survival and proliferation, thus confirming its primordial role as
central actor in the protection of a multicellular organism’s integrity
[21]. Interestingly, the highly conserved protein UBIQ (ubiquitin)
ranksatposition9(Table2),whileotherwell-knowninhibitorsofNF-
kB, IKKB, IKKE, IKKA and IKBA rank at position 10, 12, 16 and
24, respectively. The presence at such top ranking positions of factors
Figure 2. Datasets DI, U and MC share a relatively low number
of proteins, as reported by the figures in the intersections.
Datasets are quite differentiated in their composition and share only
the 2.6% of the whole UNION set (16 out of 622).
doi:10.1371/journal.pone.0032678.g002
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indication of the centrality of this complex, which, due to its
pleiotropic effects, must be tightly controlled [93].
We observed a limited degree of overlapping among the sets
(Fig. 2): DI and U share only the 9.1% of their elements, DI and
MC the 6.4%, U and MC the 13.6%, while only the 2.6% of the
elements are shared by all three interactomes (16 out of 622).
These numbers partly reflect the difference and dishomogeneity in
sources, databases, data types and relative retrieval method that
have been used. Nevertheless, we did not expect such remarkable
Table 1. summary of main network parameters of NF-kB upstream protein interactomes DI, UI, MCI and UNION and
overrepresented KEGG pathways (p,0.05).
Intera
ctome
No of p
roteins
No of
interactions
Avg
neigbours/
density Centraliz Main overrepresented KEGG pathways
% of pathway
covered
%o f
interactome
DI 377 4119 21.1/0.056 0.591 hsa03010 Ribosome 28.8 7.2
hsa03050 Proteasome 21.8 3.2
hsa04623 Cytosolic DNA-sensing pathway 21.4 3.2
hsa04622 RIG-I-like receptor signaling pathway 19.7 4.0
hsa05215 Prostate cancer 18.9 4.5
hsa04621 NOD-like receptor signaling pathway 18.9 3.5
hsa04662 B cell receptor signaling pathway 18.7 3.7
hsa04920 Adipocytokine signaling pathway 18.0 3.7
hsa04620 Toll-like receptor signaling pathway 17.6 5.0
hsa03020 RNA polymerase 17.1 1.6
U 210 568 4.6/0.022 0.185 hsa04623 Cytosolic DNA-sensing pathway 40.0 9.6
hsa04622 RIG-I-like receptor signaling pathway 32.0 10.5
hsa04621 NOD-like receptor signaling pathway 29.4 8.7
hsa04620 Toll-like receptor signaling pathway 26.2 12.2
hsa03020 RNA polymerase (22.9) 22.9 3.5
hsa04210 Apoptosis 18.5 7.4
hsa04662 B cell receptor signaling pathway 17.6 5.7
hsa04920 Adipocytokine signaling pathway 16.9 5.7
hsa05222 Small cell lung cancer 14.4 5.7
hsa04660 T cell receptor signaling pathway 13.2 6.6
MC 141 853 11.0/0.078 0.232 hsa03050 Proteasome 54.0 19.2
hsa04210 Apoptosis 27.2 17.7
hsa04662 B cell receptor signaling pathway 21.6 11.4
hsa04620 Toll-like receptor signaling pathway 20.6 15.6
hsa04622 RIG-I-like receptor signaling pathway 20.0 10.6
hsa04621 NOD-like receptor signaling pathway 19.1 9.2
hsa05222 Small cell lung cancer 17.8 11.4
hsa04920 Adipocytokine signaling pathway 16.9 9.2
hsa04660 T cell receptor signaling pathway 16.7 13.5
hsa04722 Neurotrophin signaling pathway 16.7 14.9
UNION 622 6115 18.9/0.030 0.360 hsa03050 Proteasome 62.0 5.0
hsa04621 NOD-like receptor signaling pathway 40.6 4.5
hsa04620 Toll-like receptor signaling pathway 38.0 6.6
hsa04623 Cytosolic DNA-sensing pathway 37.5 3.4
hsa03020 RNA polymerase 34.3 1.9
hsa04622 RIG-I-like receptor signaling pathway 34.2 4.2
hsa04210 Apoptosis 33.3 5.0
hsa04662 B cell receptor signaling pathway 30.7 3.7
hsa05222 Small cell lung cancer 29.7 4.3
hsa03010 Ribosome 28.7 4.3
See main text for further comments and explanations. Complete datasets available in Table S3.
doi:10.1371/journal.pone.0032678.t001
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not be totally explained simply taking into account the wide
differences in data sources and the integrative approach used, but,
on the contrary, should cast some doubts about the adequacy and
the completeness of the classical pathway descriptions.
Another example of such inadequacy is the fact that from the
analysis of the datasets TAK1 (MAP3K7) did not result to be high
ranking, as it would be expected [94].
By using the Babelomics platform, we analyzed all the sets to
identify the metabolic or signalling pathways which elements are
shared with the given sets. In Table 1 we show the first ten over-
represented pathways in the DI, U, MC and UNION according to
this analysis. The complete lists of KEGG significant terms (p-
value,0.05) are available in the Table S3. We noted that 5
KEGG pathways resulted as ranking within the top 10 in DI, U,
and MC, and that 4 out of 5 are pathways linked to the induction
of innate immunity response and inflammation (Toll-like receptor
signaling pathway; RIG-I-like receptor signalling pathway; NOD-
like receptor signalling pathway; Adipocytokine signalling path-
way). This confirms that, even if the sources of these sets are very
different, our analysis was able to capture the role of NF-kBa s
mediator of inflammation. Interestingly, MAPK pathway ranks
always high in terms of percentage of proteins present in all three
protein sets, indicating that also signal transduction leading to NF-
kB activation is a process whose component are captured by our
analysis. The UNION set resumes the characteristics of the three
and represents, in number of components, 62% of the whole
KEGG-annotated proteasome and 41% of the NOD signalling
pathway, among others.
Downstream gene and protein set: composition and
characteristics
The same KEGG analysis has been done on NF-kB
downstream gene set (410 out of 426 identifiers have been
recognized by the Babelomics analysis suite). Among the top 10
identified pathways (Table 3), four are involved in inflammation
(Toll-like receptor signalling pathway; NOD-like receptor signal-
ling pathway; cytosolic DNA-sensing pathway; cytokine-cytokine
receptor interaction), with two of them also shared by the DI, U
and MC sets. The analysis has also pointed out that relevant
subsets of DG are related to pathologies with well-known
inflammatory aetiology, such as bladder and prostate cancers,
among others.
We noted that 49 proteins are present in both UNION and DG
sets (Table 4), thus meaning that 13% of the identified NF-kB-
regulated genes express proteins that play a direct role in the
UNION interactome (Figure 3). These data suggest that the
implication of such feedback loop in the dynamics of the
interactome and in its regulation and activation of NF-kB may
be remarkable. The ability of NF-kB to control the transcription of
a non negligible part of its activation pathway interactome surely
deserves a deeper attention. Since NF-kB is a constitutively
expressed protein complex, and since it has a crucial importance in
the regulation of fundamental tasks such as the immune responses
Table 2. First 25 most central proteins (betweenness centrality) in UNION interactome (in bold the NF-kB components).
Rank Protein ID Betwn Centr Protein description NCBI gene name
1 TF65 0.21071004 Transcription factor p65 RELA
2 NFKB1 0.08342206 Nuclear factor NF-kappa-B p105 subunit NFKB1
3 TRAF6 0.07545745 TNF receptor-associated factor 6 TRAF6
4 NFKB2 0.07071487 Nuclear factor NF-kappa-B p100 subunit NFKB2
5 RELB 0.0393886 Transcription factor RelB RELB
6 NEMO 0.03913555 NF-kappa-B essential modulator IKBKG
7 TRAF2 0.03567854 TNF receptor-associated factor 2 TRAF2
8 SRC 0.03049217 Proto-oncogene tyrosine-protein kinase Src SRC
9 UBIQ 0.02940406 Ubiquitin RPS27A
10 IKKB 0.02905882 Inhibitor of nuclear factor kappa-B kinase subunit beta IKBKB
11 HSP7C 0.02826285 Heat shock cognate 71 kDa protein HSPA8
12 IKKE 0.02712651 Inhibitor of nuclear factor kappa-B kinase subunit epsilon IKBKE
13 MYC 0.0253939 Myc proto-oncogene protein MYC
14 HS90A 0.02399683 Heat shock protein HSP 90-alpha HSP90AA1
15 ESR1 0.02195341 Estrogen receptor ESR1
16 IKKA 0.02094338 Inhibitor of nuclear factor kappa-B kinase subunit alpha CHUK
17 BTK 0.0202242 Tyrosine-protein kinase BTK BTK
18 IRAK1 0.01966103 Interleukin-1 receptor-associated kinase 1 IRAK1
19 M3K3 0.01862895 Mitogen-activated protein kinase kinase kinase 3 MAP3K3
20 P53 0.0165347 Tumor suppressor gene p53 TP53
21 REL 0.01543792 C-Rel proto-oncogene protein REL
22 RIPK2 0.01533207 Receptor-interacting serine/threonine-protein kinase 2 RIPK2
23 BCL10 0.01434518 B-cell lymphoma/leukemia 10 BCL10
24 IKBA 0.01433697 NF-kappa-B inhibitor alpha NFKBIA
25 STAT3 0.01373161 Signal transducer and activator of transcription 3 STAT3
doi:10.1371/journal.pone.0032678.t002
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malfunctions and inappropriate activation.
Several feedback loops are already well-known and studied in
the literature, while many others have not been taken under
consideration in the perspective of the possible implications in the
regulation of the NF-kB pathway dynamics. In fact, as already
reported in literature and confirmed by our analysis (Table 4), NF-
kB complexes directly control the expression of their own subunits
with the exception of TF65 [14]. Thus, NF-kB system appears to
be very tightly self-regulated.
Discussion
As mentioned in the introduction, an increase of inflammatory
markers has been described as a general feature of the ageing
process and proposed as a possible cause of many age-associated
diseases. Therefore, the system of NF-kB is likely a crucial player in
this process. In this perspective, in order to understand how the
changes in composition and abundance of the NF-kB interactome
can regulate NF-kB activation, and thus (at least in part) the ageing
process,theknowledgeaboutNF-kB pathwayaswellastheproteins
that can interact directly or indirectly with it must be broaden. To
this purpose, we integrated data from multiple existing sources in
order to chart the NF-kB interactome map. Our map may help in
improving the understanding of complex signalling networks and
highlightstheimpact of single elements,their feedback and crosstalk
regulations on cellular processes [26]. Beside confirming previous
studies and insights [22], the integrative effort proposed here in
merging existing, freely available data highlights that the number of
elements impinging upon NF-kB-activating pathway outcomes is
much higher than that usually taken under consideration in
canonical pathway representations.
Furthermore, as other pleiotropic factors that receive many
inputs and spread out many outputs, NF-kB core elements are at
the centre of a network characterised by a bow tie architecture
[95], with a fan in (UNION interactome), a knob (the NF-kB
family), a fan out (downstream genes modulated by NF-kB) and
feedback loops. This is not surprising, since the bow tie might
represent an economical and efficient way to convey on the same
target different stimuli to which cells and organs are exposed
[95,96]. Moreover, bow tie architecture may be an advantageous
solution for the evolution of complex systems, because it would
minimize the number of central molecular mediators, ultimately
reducing energy expenditure for both the integration of stimuli
and the determination of the outcome [97,98]. Bow ties are
considered to be fundamental in explaining the coexistence of
robustness and evolvability in complex systems due to their ability
to facilitate control [95,99–102]. Another striking feature of bow
ties’ functioning is their inner resilience characterised by the
presence of regulatory feedback loop, i.e. some products of the fan
out are also part of the fan in. In this case the NF-kB system fits
perfectly with this architecture, as we checked for proteins present
in both the UNION interactome and DG set, thus establishing a
feedback loop of the type: interaction with NF-kB pathway R
transcription factor activation R transcriptional regulation R interaction with
NF-kB pathway (Table 4). Concerning such feedbacks, we report
three cases that were correctly captured by our analysis. The
Tumor suppressor protein p53 –that appears among the
‘‘feedback’’ proteins- can be transcriptionally induced by NF-kB
[103–105], among others. On its side, p53 can interfere with NF-
kB activity [106,107] thus creating a sort of negative feedback loop
between the two factors. The two factors not only interact with
each other, but also cooperate or compete (depending upon
circumstances) to activate downstream genes [108,109]. The
Table 3. Overrepresented pathways in DG (p,0.05), first 20 terms ranked for percentage of DG proteins present in KEGG pathway
(‘‘% of set’’ column).
KEGG ID Pathway Total terms in KEGG pathway Terms in set and pathway % of set % of pathway
hsa04060 Cytokine-cytokine receptor interaction 271 70 17,07 25,83
hsa04062 Chemokine signaling pathway 186 30 7,32 16,13
hsa04630 Jak-STAT signaling pathway 154 26 6,34 16,88
hsa04620 Toll-like receptor signaling pathway 101 23 5,61 22,77
hsa05222 Small cell lung cancer 90 19 4,63 21,11
hsa04621 NOD-like receptor signaling pathway 62 17 4,15 27,42
hsa05215 Prostate cancer 88 17 4,15 19,32
hsa04210 Apoptosis 86 16 3,90 18,60
hsa04940 Type I diabetes mellitus 90 16 3,90 17,78
hsa04672 Intestinal immune network for IgA production 84 15 3,66 17,86
hsa05330 Allograft rejection 84 15 3,66 17,86
hsa04640 Hematopoietic cell lineage 87 15 3,66 17,24
hsa05332 Graft-versus-host disease 87 13 3,17 14,94
hsa05219 Bladder cancer 42 12 2,93 28,57
hsa04115 p53 signaling pathway 67 11 2,68 16,42
hsa05218 Melanoma 70 11 2,68 15,71
hsa05212 Pancreatic cancer 71 11 2,68 15,49
hsa04623 Cytosolic DNA-sensing pathway 55 10 2,44 18,18
hsa05340 Primary immunodeficiency 41 9 2,20 21,95
hsa05014 Amyotrophic lateral sclerosis 57 9 2,20 15,79
doi:10.1371/journal.pone.0032678.t003
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Protein ID Protein Description NCBI gene name
ANDR Androgen receptor AR
BCL3 B-cell lymphoma 3-encoded protein BCL3
BIRC4 Baculoviral IAP repeat-containing protein 4 BIRC4
BLNK B-cell linker protein BLNK
BTK Tyrosine-protein kinase BTK BTK
CAV1 Caveolin-1 CAV1
CFLAR CASP8 and FADD-like apoptosis regulator CFLAR
EGR1 Early growth response protein 1 EGR1
ELF3 ETS-related transcription factor Elf-3 ELF3
ERBB2 Receptor tyrosine-protein kinase erbB-2 ERBB2
GCR Glucocorticoid receptor NR3C1
HS90A Heat shock protein HSP 90-alpha HSP90AA1
IKBA NF-kappa-B inhibitor alpha NFKBIA
IKBE NF-kappa-B inhibitor epsilon NFKBIE
IKBZ NF-kappa-B inhibitor zeta NFKBIZ
IL2RA Interleukin-2 receptor alpha chain IL2RA
IL32 Interleukin-32 IL32
IRF1 Interferon regulatory factor 1 IRF1
IRF2 Interferon regulatory factor 2 IRF2
KISS1 Metastasis-suppressor KiSS-1 KISS1
LYSC Lysozyme C LYZ
MYC Myc proto-oncogene protein MYC
NFKB1 Nuclear factor NF-kappa-B p105 subunit NFKB1
NFKB2 Nuclear factor NF-kappa-B p100 subunit NFKB2
NOD2 Nucleotide-binding oligomerization domain-containing protein 2 NOD2
NUAK2 NUAK family SNF1-like kinase 2 NUAK2
OLR1 Oxidized low-density lipoprotein receptor 1 OLR1
P53 Tumor suppressor gene p53 TP53
PRGR Progesterone receptor PGR
PSA2 Proteasome subunit alpha type-2 PSMA2
PSB9 Proteasome subunit beta type-9 PSMB9
PTEN Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase PTEN PTEN
REL C-Rel proto-oncogene protein REL
RELB Transcription factor RelB RELB
RIPK2 Receptor-interacting serine/threonine-protein kinase 2 RIPK2
TCAM1 TIR domain-containing adapter molecule 1 TICAM1
TERT Telomerase reverse transcriptase TERT
TGM2 Protein-glutamine gamma-glutamyltransferase 2 TGM2
TIFA TRAF-interacting protein with FHA domain-containing protein A TIFA
TLR2 Toll-like receptor 2 TLR2
TLR9 Toll-like receptor 9 TLR9
TNAP3 Tumor necrosis factor, alpha-induced protein 3 TNFAIP3
TNF15 Tumor necrosis factor ligand superfamily member 15 TNFSF15
TNIP1 TNFAIP3-interacting protein 1 TNIP1
TNIP3 TNFAIP3-interacting protein 3 TNIP3
TRAF1 TNF receptor-associated factor 1 TRAF1
TRAF2 TNF receptor-associated factor 2 TRAF2
TWST1 Twist-related protein 1 TWIST1
VIME Vimentin VIM
NF-kB controls the transcription of hundreds of genes. Forty-nine of them code for proteins that belong to the UNION interactome, i.e. that participate in the activation
of NF-kB. The circuit ‘‘interaction with NF-kB pathway R transcription factor activation R transcriptional regulation R interaction with NF-kB pathway’’ establishes a
number of feedback loops that can play a role in the dynamics of the NF-kB system. In bold the four NF-kB components which transcription is regulated by NF-kB itself.
doi:10.1371/journal.pone.0032678.t004
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NF-kB and PTEN, a ‘‘feedback’’ protein, that may serve to
balance their mutually antagonistic functions. Indeed, PTEN is
down-regulated by NF-kB and is able to negatively regulate NF-
kB, establishing a complex regulation which determines cell
survival or apoptosis [110,111]. The ‘‘feedback’’ ubiquitin-editing
protein TNAP3 (TNFAIP3) has been described as a key player in
the termination of NF-kB signaling and in controlling NF-kB-
dependent inflammation [112]. In most cell types basal TNAP3
expression is very low but its transcription is rapidly induced upon
NF-kB activation. Once expressed, TNAP3 functions as a negative
feedback regulator of NF-kB activation [112].
Based upon these evidences, we propose that a comprehensive
and systemic consideration of ‘‘feedback’’ genes may complement
important findings in autoregulatory feedback loops [113] leading
to a deeper understanding of the complex NF-kB regulation and
dependent inflammation. In this perspective, the observation of a
number of feedback loops deserves a deeper systemic and
experimental investigation, since these interactions might be
potential critical points for the NF-kB system regulation neglected
so far. In this direction, results from this interactome reconstruc-
tion can be used as preliminary screening to identify putative key
regulators of NF-kB system.
In summary, substantial divergences in the composition of the
DI, U and MC sets open questions about the adequacy and
comprehensiveness of classical pathway descriptions and repre-
sentations, and suggest the participation of a number of proteins
one order of magnitude higher than that classically taken into
consideration, thus transforming the concept of pathway from an
isolated entity into an open, unbound one. The map as it is
introduced here provides a tool to explore the complexity of the
NF-kB system and to make useful qualitative predictions regarding
key regulators and mediators of its activating signalling cascade,
but it is only a first step in this direction. The next steps will be not
only the obvious and continuous updates of existing records and
newly produced data, but also the charting of the interactome of
the different NF-kB components, and the analysis of interacting
proteins taking into account their sub-cellular compartmentaliza-
tion, which is currently one of most promising perspective for the
elucidation of the mechanisms related to ageing [114]. To this
regards, it is also plausible that NF-kB interactome can be
differently charted considering as a variable the five NF-kB
members, as well as the sub-cellular localisation of its components
(e.g. nucleus, organelles, membranes, cytoplasm).
A further important step will consist in charting cell type-
specific, and time-dependent interactomes, able to show maps of
various cellular functions, given that NF-kB has not only a major
role in inflammatory status but it has also a crucial role in neuronal
cells, for instance in the Schwann cell myelination, at least in
mouse models [115]. Dynamic analysis of interactomes is the next
fascinating aim, crucial for the better understanding of protein-
protein interactions when data from time-resolved proteomics will
be completely available, together with an adequate mathematical
and algorithmic contribution [116,117]. This approach could be
extremely relevant to definitively disentangle when, where and
how protein-protein interactions give their contribution to the
different functional levels of cell systems (different types of cells,
tissues, different responses to various stimuli etc). To this regard,
network inference based on the huge amount of data gathered in
the Omics era might represent a successful approach [118].
As a whole, the results of the integrative approach shown and
reported here are meant to be used as a starting point to identify
new roles of NF-kB in physiology and diseases. The integrated
analysis we performed identified elements and pathways that are
not immediately linked to NF-kB itself, or not taken into
consideration in respect to its regulation and dynamics, and may
thus suggest new directions for further studies and analyses.
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Figure 3. The UNION interactome is composed by 622 proteins,
including the five NF-kB subunits. NF-kB is able to regulate the
expression of 426 proteins (DG set, see main text). A subset (384
proteins, present in the APID database, out of 426) has been checked for
PPIs (see Dataset S1). Forty nine proteins are shared by both the UNION
and the DG sets, establishing a feedback loop: ‘‘interaction with NF-kB
pathway R transcription factor activation R transcriptional regulation R
interaction with NF-kB pathway’’, meaning that 13% of the identified NF-
kB-regulated genes express proteins that play a direct role in the UNION
interactome.
doi:10.1371/journal.pone.0032678.g003
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